Log in to save to my catalogue

Development of Monoclonal Antibody Therapeutics for Alzheimer's Disease

Development of Monoclonal Antibody Therapeutics for Alzheimer's Disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b6ae74af2b174ed4bf0e820eb13f3aa8

Development of Monoclonal Antibody Therapeutics for Alzheimer's Disease

About this item

Full title

Development of Monoclonal Antibody Therapeutics for Alzheimer's Disease

Author / Creator

Publisher

台灣精神醫學會

Journal title

Taiwan jing shen yi xue = Taiwanese journal of psychiatry, 2022-10, Vol.36 (4), p.148-156

Language

English

Formats

Publication information

Publisher

台灣精神醫學會

More information

Scope and Contents

Contents

Background: In a previous review article in the Taiwanese Journal of Psychiatry (Takeda and Tagami: Taiwanese J. Psychiatry 2020; 34: 152-61), we gave the development status of drugs for Alzheimer's disease, presented a relatively pessimistic view, and highlighted the difficulties in their development. Methods: Since I have witnessed some encouragi...

Alternative Titles

Full title

Development of Monoclonal Antibody Therapeutics for Alzheimer's Disease

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b6ae74af2b174ed4bf0e820eb13f3aa8

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b6ae74af2b174ed4bf0e820eb13f3aa8

Other Identifiers

ISSN

1028-3684

E-ISSN

2666-2078

DOI

10.4103/TPSY.TPSY_31_22

How to access this item